Compound ID | 1862
Synonym(s): ICI 194,660
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases |
Description: | Semisynthetic, derived from thienamycin. Fixed combinations with various beta-lactamase inhibitors |
Institute where first reported: | Pfizer |
Year first mentioned: | 1983 |
Highest developmental phase: | Approved by FDA in 1996 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H](C(=O)N(C)C)NC3)C(=O)O |
Isomeric SMILES: | C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O |
InChI: | InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1 |
InChI Key: | DMJNNHOOLUXYBV-PQTSNVLCSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/441130 |
External links: | |
Guide to Pharmacology: | meropenem |
Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC245547/ |
Citations: |
|